Open AccessNanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice
Author(s) -
Muhammed A. Saad,
Noha M Eissa,
M Ahmed,
Aliaa Nabil ElMeshad,
Götz Laible,
Ahmed S. Attia,
Medhat A. AlGhobashy,
Rania M. Abdelsalam,
Muhammad Y. AlShorbagy
Publication year - 2022
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s359114
Subject(s) - experimental autoimmune encephalomyelitis , myelin oligodendrocyte glycoprotein , multiple sclerosis , myelin , tumor necrosis factor alpha , medicine , myelin basic protein , immunology , encephalomyelitis , interleukin , pharmacology , cytokine , central nervous system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom